enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Management of multiple sclerosis - Wikipedia

   en.wikipedia.org/wiki/Management_of_multiple...

   Oral contraceptive pills have contradictory results from different studies regarding any effect of decreasing relapse rate in women with multiple sclerosis. [77] Certain medications for MS symptoms, such as carbamazepine (used to treat spasms and pain) and modafinil (used to treat fatigue) can make oral contraceptive pills less effective. [77]

3. Ocrelizumab - Wikipedia

   en.wikipedia.org/wiki/Ocrelizumab

   Ocrelizumab, sold under the brand name Ocrevus, is a medication used for the treatment of multiple sclerosis. It is a humanized anti- CD20 monoclonal antibody . [ 8 ] It targets CD20 marker on B lymphocytes and is an immunosuppressive drug . [ 10 ]

4. Signs and symptoms of multiple sclerosis - Wikipedia

   en.wikipedia.org/wiki/Signs_and_symptoms_of...

   It may be that primary MS fatigue is unaffected by sleep characteristics, but that sleep deprivation correlates with secondary MS fatigue. [155] CPAP treatment in patients with MS and sleep apnea may reduce fatigue and improve the physical quality of life. [156]

5. New treatment may stop and potentially reverse some nerve ...

   www.aol.com/treatment-may-stop-potentially...

   Multiple sclerosis (MS) is an autoimmune disorder in which the immune system attacks and destroys the myelin sheath of nerve cells. It most commonly strikes people between the ages of 20 and 40.

6. Modafinil - Wikipedia

   en.wikipedia.org/wiki/Modafinil

   People with multiple sclerosis often report increased energy levels, reduced feelings of tiredness, improved cognitive function, and an overall improvement in their quality of life when taking modafinil. [43] While modafinil can provide relief from MS-related fatigue symptoms, [43] it does not treat the underlying cause or cure MS itself. The ...

7. Ofatumumab - Wikipedia

   en.wikipedia.org/wiki/Ofatumumab

   Ofatumumab is a fully human monoclonal antibody to CD20, which appears to provide rapid B-cell depletion. [13] Under the brand name Kesimpta, it is approved for the treatment of multiple sclerosis in the United States as well as in the European Union and other regions.